カテゴリ： 世界, 医療/バイオ, QYResearch

BCGワクチンの世界市場2023年：免疫、治療

■ 英語タイトル：Global Bacille Calmette-Guérin Vaccine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8688）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8688
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[BCGワクチンの世界市場2023年：免疫、治療]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はBCGワクチンのグローバル市場について調査・分析し、世界のBCGワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（免疫、治療）、用途別セグメント分析（3ヶ月以下乳児、5IUPPD陰性子供）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、Serum Institute of India、GSBPLなどが含まれています。BCGワクチンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、BCGワクチン市場規模を算出する際に考慮しました。

・BCGワクチン市場の概要
- 製品の定義
- BCGワクチンの種類別セグメント
- 世界のBCGワクチン市場規模：タイプ別分析（免疫、治療）
- BCGワクチンの用途別セグメント
- 世界のBCGワクチン市場規模：用途別分析（3ヶ月以下乳児、5IUPPD陰性子供）
- 世界のBCGワクチン市場規模予測（2018年-2029年）
- BCGワクチンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- BCGワクチン市場の競争状況およびトレンド

・BCGワクチンの地域別市場規模
- 北米のBCGワクチン市場規模（2018年-2029年）
- 米国のBCGワクチン市場規模（2018年-2029年）
- ヨーロッパのBCGワクチン市場規模（2018年-2029年）
- アジア太平洋のBCGワクチン市場規模（2018年-2029年）
- 中国のBCGワクチン市場規模（2018年-2029年）
- 日本のBCGワクチン市場規模（2018年-2029年）
- 韓国のBCGワクチン市場規模（2018年-2029年）
- インドのBCGワクチン市場規模（2018年-2029年）
- オーストラリアのBCGワクチン市場規模（2018年-2029年）
- 中南米のBCGワクチン市場規模（2018年-2029年）
- 中東・アフリカのBCGワクチン市場規模（2018年-2029年）

・種類別セグメント：免疫、治療
- 世界のBCGワクチンのタイプ別販売量（2018年-2023年）
- 世界のBCGワクチンのタイプ別売上（2018年-2023年）
- 世界のBCGワクチンのタイプ別価格

・用途別セグメント：3ヶ月以下乳児、5IUPPD陰性子供
- 世界のBCGワクチンの用途別販売量（2018年-2023年）
- 世界のBCGワクチンの用途別売上（2018年-2023年）
- 世界のBCGワクチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、Serum Institute of India、GSBPL

・産業チェーンと販売チャネルの分析
- BCGワクチン産業チェーン分析
- BCGワクチンの主要原材料
- BCGワクチンの販売チャネル
- BCGワクチンのディストリビューター
- BCGワクチンの主要顧客

・BCGワクチン市場ダイナミクス
- BCGワクチンの業界動向
- BCGワクチン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Bacille Calmette-Guérin Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bacille Calmette-Guérin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bacille Calmette-Guérin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bacille Calmette-Guérin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India and GSBPL, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guérin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guérin Vaccine.
The Bacille Calmette-Guérin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bacille Calmette-Guérin Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacille Calmette-Guérin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
GSBPL
Segment by Type
Immune Bacille Calmette-Guérin
Therapy Bacille Calmette-Guérin
Segment by Application
Infants Under 3 Months
Children Test Negative With 5IUPPD
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacille Calmette-Guérin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacille Calmette-Guérin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Bacille Calmette-Guérin Vaccine Market Overview
1.1 Product Overview and Scope of Bacille Calmette-Guérin Vaccine
1.2 Bacille Calmette-Guérin Vaccine Segment by Type
1.2.1 Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Immune Bacille Calmette-Guérin
1.2.3 Therapy Bacille Calmette-Guérin
1.3 Bacille Calmette-Guérin Vaccine Segment by Application
1.3.1 Global Bacille Calmette-Guérin Vaccine Market Value by Application: (2023-2029)
1.3.2 Infants Under 3 Months
1.3.3 Children Test Negative With 5IUPPD
1.4 Global Bacille Calmette-Guérin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guérin Vaccine Revenue 2018-2029
1.4.2 Global Bacille Calmette-Guérin Vaccine Sales 2018-2029
1.4.3 Global Bacille Calmette-Guérin Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guérin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bacille Calmette-Guérin Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Bacille Calmette-Guérin Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Product Type & Application
2.7 Bacille Calmette-Guérin Vaccine Market Competitive Situation and Trends
2.7.1 Bacille Calmette-Guérin Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacille Calmette-Guérin Vaccine Players Market Share by Revenue
2.7.3 Global Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacille Calmette-Guérin Vaccine Retrospective Market Scenario by Region
3.1 Global Bacille Calmette-Guérin Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bacille Calmette-Guérin Vaccine Global Bacille Calmette-Guérin Vaccine Sales by Region: 2018-2029
3.2.1 Global Bacille Calmette-Guérin Vaccine Sales by Region: 2018-2023
3.2.2 Global Bacille Calmette-Guérin Vaccine Sales by Region: 2024-2029
3.3 Global Bacille Calmette-Guérin Vaccine Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2018-2029
3.3.1 Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2018-2023
3.3.2 Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2024-2029
3.4 North America Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.4.3 North America Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.5.3 Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guérin Vaccine Sales by Type (2018-2029)
4.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Type (2018-2023)
4.1.2 Global Bacille Calmette-Guérin Vaccine Sales by Type (2024-2029)
4.1.3 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2018-2029)
4.2.1 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2018-2023)
4.2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2024-2029)
4.2.3 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Bacille Calmette-Guérin Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bacille Calmette-Guérin Vaccine Sales by Application (2018-2029)
5.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Application (2018-2023)
5.1.2 Global Bacille Calmette-Guérin Vaccine Sales by Application (2024-2029)
5.1.3 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2018-2029)
5.2.1 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2018-2023)
5.2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2024-2029)
5.2.3 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Bacille Calmette-Guérin Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Bacille Calmette-Guérin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 China National Biotec Bacille Calmette-Guérin Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute of India Bacille Calmette-Guérin Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GSBPL Bacille Calmette-Guérin Vaccine Product Portfolio
6.6.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guérin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guérin Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guérin Vaccine Production Mode & Process
7.4 Bacille Calmette-Guérin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guérin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guérin Vaccine Distributors
7.5 Bacille Calmette-Guérin Vaccine Customers
8 Bacille Calmette-Guérin Vaccine Market Dynamics
8.1 Bacille Calmette-Guérin Vaccine Industry Trends
8.2 Bacille Calmette-Guérin Vaccine Market Drivers
8.3 Bacille Calmette-Guérin Vaccine Market Challenges
8.4 Bacille Calmette-Guérin Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Bacille Calmette-Guérin Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Bacille Calmette-Guérin Vaccine Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Bacille Calmette-Guérin Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Bacille Calmette-Guérin Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Bacille Calmette-Guérin Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacille Calmette-Guérin Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacille Calmette-Guérin Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacille Calmette-Guérin Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Bacille Calmette-Guérin Vaccine Sales by Region (2018-2023) & (Units)
Table 18. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Bacille Calmette-Guérin Vaccine Sales by Region (2024-2029) & (Units)
Table 20. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Bacille Calmette-Guérin Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Bacille Calmette-Guérin Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Bacille Calmette-Guérin Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Bacille Calmette-Guérin Vaccine Sales by Country (2018-2023) & (Units)
Table 27. North America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2029) & (Units)
Table 28. North America Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Bacille Calmette-Guérin Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Bacille Calmette-Guérin Vaccine Sales by Country (2018-2023) & (Units)
Table 32. Europe Bacille Calmette-Guérin Vaccine Sales by Country (2024-2029) & (Units)
Table 33. Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Bacille Calmette-Guérin Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2018-2023) & (Units)
Table 42. Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2029) & (Units)
Table 43. Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Type (2018-2023)
Table 51. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Type (2024-2029)
Table 52. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Application (2018-2023)
Table 61. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Application (2024-2029)
Table 62. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Bacille Calmette-Guérin Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Japan BCG Lab Bacille Calmette-Guérin Vaccine Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. China National Biotec Corporation Information
Table 86. China National Biotec Description and Business Overview
Table 87. China National Biotec Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. China National Biotec Bacille Calmette-Guérin Vaccine Product
Table 89. China National Biotec Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Serum Institute of India Bacille Calmette-Guérin Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. GSBPL Corporation Information
Table 96. GSBPL Description and Business Overview
Table 97. GSBPL Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. GSBPL Bacille Calmette-Guérin Vaccine Product
Table 99. GSBPL Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Bacille Calmette-Guérin Vaccine Distributors List
Table 103. Bacille Calmette-Guérin Vaccine Customers List
Table 104. Bacille Calmette-Guérin Vaccine Market Trends
Table 105. Bacille Calmette-Guérin Vaccine Market Drivers
Table 106. Bacille Calmette-Guérin Vaccine Market Challenges
Table 107. Bacille Calmette-Guérin Vaccine Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bacille Calmette-Guérin Vaccine
Figure 2. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Bacille Calmette-Guérin Vaccine Market Share by Type in 2022 & 2029
Figure 4. Immune Bacille Calmette-Guérin Product Picture
Figure 5. Therapy Bacille Calmette-Guérin Product Picture
Figure 6. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Bacille Calmette-Guérin Vaccine Market Share by Application in 2022 & 2029
Figure 8. Infants Under 3 Months
Figure 9. Children Test Negative With 5IUPPD
Figure 10. Global Bacille Calmette-Guérin Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Bacille Calmette-Guérin Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Bacille Calmette-Guérin Vaccine Sales (2018-2029) & (Units)
Figure 13. Global Bacille Calmette-Guérin Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Bacille Calmette-Guérin Vaccine Report Years Considered
Figure 15. Bacille Calmette-Guérin Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Bacille Calmette-Guérin Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Bacille Calmette-Guérin Vaccine Players: Market Share by Revenue in 2022
Figure 18. Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Bacille Calmette-Guérin Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Bacille Calmette-Guérin Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Bacille Calmette-Guérin Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Bacille Calmette-Guérin Vaccine by Type (2018-2029)
Figure 54. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Bacille Calmette-Guérin Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Bacille Calmette-Guérin Vaccine by Application (2018-2029)
Figure 57. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Bacille Calmette-Guérin Vaccine Value Chain
Figure 59. Bacille Calmette-Guérin Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 細胞培養系インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • セービン不活化ポリオワクチン（sIPV）の世界市場2023年：バイアル、シリンジ
  • 帯状疱疹ワクチンのグローバル市場展望 2023年-2029年：生、組換え
  • VLPベースワクチンの世界市場2023年：弱毒生ワクチン、不活化ワクチン、組換えワクチン、トキソイドワクチン
  • 世界の経鼻インフルエンザワクチン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8688 )"BCGワクチンの世界市場2023年：免疫、治療" (英文：Global Bacille Calmette-Guérin Vaccine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。